ILA 2.78% 7.0¢ island pharmaceuticals limited

Ann: Approval to commence dosing 3rd cohort of ISLA-101 SAD study, page-13

  1. 19,003 Posts.
    lightbulb Created with Sketch. 5783
    The company hasn’t said. It will depend if they give us interim results or wait for the final GLP report. I suspect that we might get interim results given they need to raise capital to support the PEACH trial. Feb/March would be my best guess.

    One thing I hope ILA have done is the analysis on the early doses so they know everything is on track. It would be cheaper to do all the analysis in one batch at the end, but this comes with a lot of risk if the PK/PD doesn’t match the original formulation.
 
watchlist Created with Sketch. Add ILA (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
-0.002(2.78%)
Mkt cap ! $8.873M
Open High Low Value Volume
7.0¢ 7.0¢ 7.0¢ $350 5K

Buyers (Bids)

No. Vol. Price($)
1 8145 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 50000 1
View Market Depth
Last trade - 14.28pm 04/07/2024 (20 minute delay) ?
ILA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.